7813.T
The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
Business. The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
The company maintains a liquidity position with a current ratio of 2.32, indicating a strong ability to meet short-term obligations, supported by cash and equivalents of 172,584 million JPY. However, the liquidity risk is assessed as medium, primarily due to a negative net cash position after subtracting total debt. The price-to-book ratio of 0.94 suggests that the company is trading at a slight discount to its book value, while the price-to-tangible-book ratio is identical, indicating no significant intangible assets.
Profitability metrics show a return on equity of 6.23% and a return on assets of 3.09%, both below the industry median for medical equipment and supplies, which typically exceeds 8% and 5%, respectively. The operating margin is 2.18%, which is also below the industry median of 3.5%, suggesting room for improvement in cost management and pricing power.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the latest financial report. This lack of diversification may expose the company to regional economic or regulatory risks, particularly in Japan, where the majority of its operations are based.
Looking ahead, the company is projected to experience a modest growth in revenue, with a year-over-year increase of approximately 2.5% in the current fiscal year and a 3.0% increase in the following year. This growth trajectory is supported by a stable operating cash flow of 218,959 million JPY and a free cash flow of 65,311 million JPY, although capital expenditures have been negative, indicating asset disposals or reduced investment.
The risk assessment highlights a medium liquidity risk and a low dilution risk, with no significant dilution potential in the near term. The company's debt-to-equity ratio of 0.69 is relatively low, suggesting a conservative capital structure, but the negative net cash position after subtracting total debt remains a concern.
Recent events include the filing of the latest financial report, which disclosed a net income of 192,979 million JPY and a revenue of 8,422,729 million JPY. No significant earnings call transcripts or regulatory filings have been disclosed in the recent period, indicating a stable operational environment.
- The company has a strong current ratio of 2.32, indicating a solid short-term liquidity position.
- Return on equity and return on assets are below industry medians, suggesting lower profitability relative to peers.
- Revenue is concentrated in a single business segment with no geographic diversification disclosed.
- The company is projected to experience modest revenue growth in the next two fiscal years.
- The debt-to-equity ratio is low, but the negative net cash position after subtracting total debt is a concern.
- The risk of dilution is assessed as low, with no significant dilution potential in the near term.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- 7813.T Market data — financials · 2026-05-27
- Platz Co Ltd Market data — analyst estimates · 2026-05-27